Disclosures for "Effects of EDG-5506, a Fast Myosin Modulator, on Function and Biomarkers of Muscle Damage in Adults with Becker Muscular Dystrophy"
-
Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Biosciences. Dr. Phan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stealth.
-
Dr. Collins has received personal compensation for serving as an employee of Edgewise Therapeutics.
-
Mr. Russell has received personal compensation for serving as an employee of Edgewise Therapeutics. Mr. Russell has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Edgewise Therapeutics. Mr. Russell has stock in Edgewise Therapeutics. Mr. Russell has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Barthel has received personal compensation for serving as an employee of Edgewise Therapeutics. Dr. Barthel has stock in Edgewise Therapeutics.
-
Mrs. Thaler has nothing to disclose.
-
Ms. Kilburn has received personal compensation for serving as an employee of Edgewise Therapeutics. Ms. Kilburn has stock in Edgewise Therapeutics.
-
-
Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Actinium Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aura Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuro. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catabasis Pharmaceuticals. Mr. MacDougall has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Edgewise Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Enterin . Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurogastrx, Inc.. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Promentis. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Synlogic Therapeutics. Mr. MacDougall has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogent Biosciences. Mr. MacDougall has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Point Biopharma. Mr. MacDougall has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx.
-
Dr. Donovan has received personal compensation for serving as an employee of Edgewise Therapeutics. Dr. Donovan has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Edgewise Therapeutics. Dr. Donovan has stock in Edgewise Therapeutics.